Role of matrix metalloproteinases in recurrent corneal melting

Experimental Eye Research

Volumn 90, Issue 5, 2010, Pages 583-590

  Brejchova, Kristyna ^a   Liskova, Petra ^a   Cejkova, Jitka ^b   Jirsova, Katerina ^a,c  

^a Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Corneal melting; Extracellular matrix degradation; Matrix metalloproteinases; Ocular cicatricial pemphigoid; Rheumatoid arthritis

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN;

AGED; ARTICLE; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA MELTING; CORNEA STROMA; ENTROPION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUCOUS MEMBRANE PEMPHIGOID; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ZYMOGRAPHY; ADOLESCENT; ADULT; COMPARATIVE STUDY; DONOR; ENZYMOLOGY; MIDDLE AGED; PENETRATING KERATOPLASTY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CORNEAL DISEASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOPLASTY, PENETRATING; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; RECURRENCE; TISSUE DONORS; YOUNG ADULT;

EID: 77951235362     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.02.002     Document Type: Article

References (52)

1. Barletta J.P., Angella G., Balch K.C., Dimova H.G., Stern G.A., Moser M.T., van Setten G.B., Schultz G.S. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest. Ophthalmol. Vis. Sci. 1996, 37:20-28.
2. Berman M., Leary R., Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest. Ophthalmol. Vis. Sci. 1980, 19:1204-1221.
3. Bernauer W., Ficker L.A., Watson P.G., Dart J.K. The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes. Ophthalmology 1995, 102:1325-1337.
4. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 1993, 4:197-250.
5. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006, 11:529-543.
6. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 1996, 70:163-182.
7. Donzis P.B., Mondino B.J. Management of noninfectious corneal ulcers. Surv. Ophthalmol. 1987, 32:94-110.
8. Fini M.E., Yue B.Y., Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr. Eye Res. 1992, 11:849-862.
9. Fini M.E., Cook J.R., Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch. Dermatol. Res. 1998, 290(Suppl.):S12-S23.
10. Funderburgh J.L., Hevelone N.D., Roth M.R., Funderburgh M.L., Rodrigues M.R., Nirankari V.S., Conrad G.W. Decorin and biglycan of normal and pathologic human corneas. Invest. Ophthalmol. Vis. Sci. 1998, 39:1957-1964.
11. Gabison E.E., Chastang P., Menashi S., Mourah S., Doan S., Oster M., Mauviel A., Hoang-Xuan T. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases. Ophthalmology 2003, 110:1626-1631.
12. Giannelli G., Pozzi A., Stetler-Stevenson W.G., Gardner H.A., Quaranta V. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am. J. Pathol. 1999, 154:1193-1201.
13. Hagen K.B., Waring G.O., Johnson-Wint B. Progressive nonulcerative paracentral keratolysis associated with elevated corneal metalloproteinases. Cornea 1997, 16:486-492.
14. Hargrave S.L., Jung J.C., Fini M.E., Gelender H., Cather C., Guidera A., Udell I., Fisher S., Jester J.V., Bowman R.W., McCulley J.P., Cavanagh H.D. Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis. Ophthalmology 2002, 109:343-350.
15. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D., Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem. J. 1997, 322(Pt 3):809-814.
16. Imai K., Yokohama Y., Nakanishi I., Ohuchi E., Fujii Y., Nakai N., Okada Y. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 1995, 270:6691-6697.
17. Joseph A., Dua H.S., King A.J. Failure of amniotic membrane transplantation in the treatment of acute ocular burns. Br. J. Ophthalmol. 2001, 85:1065-1069.
18. Kenney M.C., Chwa M., Opbroek A.J., Brown D.J. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio. Cornea 1994, 13:114-124.
19. Kervick G.N., Pflugfelder S.C., Haimovici R., Brown H., Tozman E., Yee R. Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy. Ophthalmology 1992, 99:80-88.
20. Knauper V., Lopez-Otin C., Smith B., Knight G., Murphy G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 1996, 271:1544-1550.
21. Lemp M.A. Advances in understanding and managing dry eye disease. Am. J. Ophthalmol. 2008, 146:350-356.
22. Li D.Q., Shang T.Y., Kim H.S., Solomon A., Lokeshwar B.L., Pflugfelder S.C. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:2928-2936.
23. Lijnen H.R. Metalloproteinases in development and progression of vascular disease. Pathophysiol. Haemost. Thromb. 2003/2004, 33:275-281.
24. Liu H., Zhang W., Pan Z., Wu Y. Experimental study on the treatment of corneal melting after alkali burn with GM 6001. Zhonghua Yan Ke Za Zhi 2002, 38:539-542.
25. Ljubimov A.V., Burgeson R.E., Butkowski R.J., Michael A.F., Sun T.T., Kenney M.C. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab. Invest. 1995, 72:461-473.
26. Mackiewicz Z., Maatta M., Stenman M., Konttinen L., Tervo T., Konttinen Y.T. Collagenolytic proteinases in keratoconus. Cornea 2006, 25:603-610.
27. Malik R., Culinane A.B., Tole D.M., Cook S.D. Rheumatoid keratolysis: a series of 40 eyes. Eur. J. Ophthalmol. 2006, 16:791-797.
28. Marshall G.E., Konstas A.G., Lee W.R. Immunogold fine structural localization of extracellular matrix components in aged human cornea. I. Types I-IV collagen and laminin. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229:157-163.
29. Marshall G.E., Konstas A.G., Lee W.R. Immunogold fine structural localization of extracellular matrix components in aged human cornea. II. Collagen types V and VI. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229:164-171.
30. Matsubara M., Zieske J.D., Fini M.E. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest. Ophthalmol. Vis. Sci. 1991, 32:3221-3237.
31. McElvanney A.M. Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature. Eye Contact Lens 2003, 29:258-261.
32. Mesa C., Mirza M., Mitsutake N., Sartor M., Medvedovic M., Tomlinson C., Knauf J.A., Weber G.F., Fagin J.A. Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling. Cancer Res. 2006, 66:6521-6529.
33. Myint E., Brown D.J., Ljubimov A.V., Kyaw M., Kenney M.C. Cleavage of human corneal type VI collagen alpha 3 chain by matrix metalloproteinase-2. Cornea 1996, 15:490-496.
34. Nakayasu K., Tanaka M., Konomi H., Hayashi T. Distribution of types I, II, III, IV and V collagen in normal and keratoconus corneas. Ophthalmic Res. 1986, 18:1-10.
35. O'Brien T.P., Li Q.J., Sauerburger F., Reviglio V.E., Rana T., Ashraf M.F. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology 2001, 108:656-659.
36. Palay D.A., Stulting R.D., Waring G.O., Wilson L.A. Penetrating keratoplasty in patients with rheumatoid arthritis. Ophthalmology 1992, 99:622-627.
37. Perez V.L., Azar D.T., Foster C.S. Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin. Ophthalmol. 2002, 17:124-130.
38. Pleyer U., Bertelmann E., Rieck P., Hartmann C. Outcome of penetrating keratoplasty in rheumatoid arthritis. Ophthalmologica 2002, 216:249-255.
39. Quesada A.R., Barbacid M.M., Mira E., Fernandez-Resa P., Marquez G., Aracil M. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Clin. Exp. Metastasis 1997, 15:26-32.
40. Riley G.P., Harrall R.L., Watson P.G., Cawston T.E., Hazleman B.L. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995, 9(Pt 6):703-718.
41. Smith V.A., Rishmawi H., Hussein H., Easty D.L. Tear film MMP accumulation and corneal disease. Br. J. Ophthalmol. 2001, 85:147-153.
42. Solomon A., Meller D., Prabhasawat P., John T., Espana E.M., Steuhl K.P., Tseng S.C. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 2002, 109:694-703.
43. Stefansson S., Aimes R.T., Seward N.B., Alexander D.S., Quigley J.P. Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts. J. Cell. Physiol. 1994, 161:419-428.
44. Twining S.S., Hatchell D.L., Hyndiuk R.A., Nassif K.F. Acid proteases and histologic correlations in experimental ulceration in vitamin A deficient rabbit corneas. Invest. Ophthalmol. Vis. Sci. 1985, 26:31-44.
45. Vajpayee R.B., Vanathi M., Tandon R., Sharma N., Titiyal J.S. Keratoplasty for keratomalacia in preschool children. Br. J. Ophthalmol. 2003, 87:538-542.
46. Vajtr D., Kukacka J., Adámek T. Findings in myocardial extracellular matrix in fatal poisoning with addictive substances. Soud Lek 2002, 47:54-58. Czech.
47. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
48. Vizoso F.J., Gonzalez L.O., Corte M.D., Rodriguez J.C., Vazquez J., Lamelas M.L., Junquera S., Merino A.M., Garcia-Muniz J.L. Study of matrix metalloproteinases and their inhibitors in breast cancer. Br. J. Cancer 2007, 96:903-911.
49. Webster N.L., Crowe S.M. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J. Leukoc. Biol. 2006, 80:1052-1066.
50. Weiss A., Goldman S., Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci. 2007, 12:649-659.
51. Wheeless C.R., Nunley J.A., Urbaniak J.R. Wheeless' Textbook of Orthopaedics 1996-2009, Duke Orthopaedics, Duke University Medical Center's Division of Orthopaedic Surgery, in Conjunction with Data Trace Internet Publishing, LLC, Durham, LC, USA. http://www.wheelessonline.com.
52. Yu W.H., Woessner J.F. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 2000, 275:4183-4191.